Shionogi, Chugai And Tsumura To Restart Operations In Quake-affected Areas
This article was originally published in PharmAsia News
Shionogi Pharma Inc. plans to restart its Iwate Prefecture-based factory producing antibiotics and cancer pain relief agents beginning April 11. After the earthquake, the factory suffered damage to equipment and Shionogi plans to prioritize items to manufacture, based on available materials and equipment condition
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.